24 March 2020
-END-
Etiqa is a true multi-channel distributor of Insurance and Takaful products via its 10,000 agency force, 46 branches and 17 offices, over 490 bancassurance network (via Maybank branches, third-party banks, as well as co-operatives and brokers) through its presence in Malaysia, Singapore, the Philippines, Indonesia and Cambodia.
28/4/2020
Eligible customers are allowed to defer having to pay their Premium for a period of 3 months, whilst continuing to enjoy protection during this 3-month period.
Etiqa is pleased to share that during this 3-month period, no administrative charges, late payment fees or interest costs will be applied, and the policy and coverage will remain intact.
You can demonstrate proof of financial diffculty due to Covid-19 with documents such as:
For example: You may have been hospitalised for 14 days due to Covid-19 but have already exceeded the number of medical leave days provided by your employer, and thus will be taking no-pay leave during the 14 days. A medical report from the hospital together with your employer’s letter of salary reduction would be the relevant documentation required.
The offer period is from 1st April to 31st December 2020. However, Etiqa Life Insurance Berhad reserves the right to change, extend or withdraw this offer at anytime without notice.
The offer allows for a deferment of 3 months, only upon request and approval within the 1st April to 31st December 2020 ffer period. For example:
Step 1: Request for deferment submitted on 14th April (which is within the 9 month offer period of 1st April to 31st December).
Step 2: Deferment request approved and commences for a period of 3 months from 15th April to 14th July).
Step 3: Premium payments to resume on 15th July.
Only a one-time deferment is allowable per policy. However, Etiqa is pleased to share that if you have multiple policies, you may submit offcial requests for deferments for all eligible policies.
During MCO period
All you have to do is reach out to us on Livechat at www.eti.qa/livechat; available 24 hours a day, 7 days a week.
Post MCO period
We are unable to share this with you at this stage, as the Government has yet to announce the guiding principles of operations post MCO. However, once we get clarity from the Government, we will provide updates of our contact points post MCO via our FB & IG social media pages.
Customers will qualify for this Cash Relief upon diagnosis of Covid-19.
The good news is that this relief is available for any and all individual customers (group customers are excluded), irrespective of what kind of plan you have with Etiqa Life Insurance Berhad.
Currently it’s planned to end on 30th June 2020. However, Etiqa Life Insurance Berhad reserves the right to change, extend or withdraw this offer at anytime without notice.
No. This relief is a one-time offer per individual.
The cash relief is RM5,000 per diagnosed individual. In the unfortunate event of more insured members being diagnosed, those members will all receive RM5,000 each.
During MCO period
All you have to do is reach out to us on Livechat at www.eti.qa/livechat; and share any offcial documentation from the hospital of your Covid-19 diagnosis together with your IC & bank account details. We’d be happy to process the RM5,000 claims payout to you.
Post MCO period
We are unable to share this with you at this stage, as the Government has yet to announce the guiding principles of operations post MCO. However, once we get clarity from the Government, we will provide updates of our contact points post MCO via our FB & IG social media pages.
This cash relief is a special/extra benefit we provide to our Etiqa Life Insurance Berhad individual customers (group customers are excluded). Thus, the existing benefits of your plan will be unaffected and remain unchanged.
As part of the contract of the plan, this would not normally be covered. However, Etiqa Life Insurance Berhad has made a special exception to cover this for all customers who own a Medical plan or Hospital Income plan with us.
The coverage amount follows your current terms of your plan. The only variation is that whilst you would not normally be covered for pandemics such as Covid-19, Etiqa Life Insurance Berhad has made an exception to provide coverage for a limited period.
Currently it’s planned to end on 30th June 2020. However, Etiqa Life Insurance Berhad reserves the right to change, extend or withdraw this offer at anytime without notice.
Etiqa is pleased to share that customers who own a Medical plan or Hospital Income plan will enjoy the benefits provided by the plan for hospitalisation due to Covid-19 at Government Hospitals.
Etiqa Life Insurance Berhad is pleased to share that we have waived the waiting period so that you can be entitled for hospitalization coverage due to Covid-19.
During MCO period
You can pay for the bill upon discharge from the government hospital and submit a reimbursement claim to Etiqa via Livechat at www.eti.qa/livechat. All you have to do is share the claim form (available via https://etiqa.com.my/v2/claims/medical), medical diagnosis report, the hospital bill & the hospital receipt (receipt to be marked with “For Etiqa only”).
Post MCO period
We are unable to share this with you at this stage, as the Government has yet to announce the guiding principles of operations post MCO. However, once we get clarity from the Government, we will provide updates of our contact points post MCO via our FB & IG social media pages.
This benefit to cover Covid-19 will utilize the allocations of your existing Etiqa Life Insurance Berhad plan.
Eligible Etiqa customers are allowed to claim a maximum RM300 reimbursement after the completion of their Covid-19 test.
All Etiqa plans which cover for Medical Expenses, Hospitalisation & Surgical, Hospital Income & Cash benefit and Critical Illness/Dread disease would be eligible.
Etiqa is pleased to share that the RM300 subsidy is applicable for both customers with positive & negative confirmation of a Covid-19 diagnosis.
Unfortunately, the test must be conducted at recognized private labs listed on the offcial website of Ministry of Health to be eligible to claim for the RM300 subsidy.
Unfortunately, you will not be eligible to claim for the RM300 subsidy as it is an elective surgery. In addition, you will also not be able to claim reimbursement from Etiqa for the test as it is not covered under the current terms of Etiqa Medical/Hospitalisation plans.
Unfortunately, you must be referred by a doctor registered with Ministry of Health to be eligible to claim for the RM300 subsidy.
The offer has been made available from 27th March 2020 and will remain available until further notice. However, please note that Etiqa has collaborated with Industry bodies & companies in the Insurance & Takaful sector to establish a total pool of RM8 Million to cater for this RM300 subsidy. Thus, this offer is on a first-come-first-served basis, and will be concluded upon utilisation of the RM8 Million pool.
Only a one-time claim is allowable per Etiqa individual, irrespective of the number of plans you may have with Etiqa.
The RM300 subsidy o er is on a per individual basis. If the other members of your family meet the eligibility criteria, then each of them will also be eligible for the offer.
Only a one-time claim is allowable per individual, irrespective of the number of plans you may have with Etiqa and other Insurance/Takaful operators.
You can pay for the test and subsequently submit a reimbursement claim. Details of the contact point & ways to submit your claim is available on the websites of LIAM (www.liam.org.my), PIAM (www.piam.org.my) and MTA (www.malaysiantakaful.com.my).
This offer is a special/extra benefit we provide to our Etiqa Life Insurance Berhad Medical or Health customers. Thus, the existing benefits of your plan will be unaffected and remain unchanged.
As part of the contract of Etiqa plans, hospitalisation & treatment for a pandemic like Covid-19 would not normally be covered. However, Etiqa has made a special exception to cover this for all customers who own an Etiqa Medical or Health plan with us.
MILG Advisory Sdn. Bhd.
Company No. 201901007753 (1317080-T)
MILG Advisory Sdn. Bhd.
Company No. 201901007753 (1317080-T)